MAG
CVS icon

MRA Advisory Group’s CVS Health CVS Stock Holding History

MRA Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,927
Closed -$414K – 117
2023
Q3 		$414K Buy
5,927
+290
+5% +$20.5K 0.3% 67
2023
Q2 		$390K Buy
5,637
+104
+2% +$7.4K 0.27% 63
2023
Q1 		$411K Sell
5,533
-567
-9% -$47.5K 0.3% 60
2022
Q4 		$569K Buy
6,100
+689
+13% +$66.5K 0.45% 45
2022
Q3 		$478K Buy
5,411
+324
+6% +$32.1K 0.41% 56
2022
Q2 		$471K Sell
5,087
-534
-10% -$52.1K 0.41% 53
2022
Q1 		$569K Sell
5,621
-1,212
-18% -$127K 0.43% 51
2021
Q4 		$705K Buy
6,833
+735
+12% +$67.9K 0.55% 46
2021
Q3 		$518K Buy
6,098
+475
+8% +$39.8K 0.44% 52
2021
Q2 		$469K Buy
5,623
+481
+9% +$39.4K 0.4% 54
2021
Q1 		$387K Buy
+5,142
New +$375K 0.36% 62

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MRA Advisory Group's CVS Position: Q4 2023 in Review

MRA Advisory Group sold out of CVS Health (CVS) in Q4 2023, closing a stake of 5,927 shares — an estimated $414K sold.

MRA Advisory Group first reported a position in CVS in Q1 2021 and held it in 11 quarters. The position peaked at $705K in Q4 2021. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • MRA Advisory Group reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • MRA Advisory Group sold 5,927 CVS Health shares in Q4 2023, an estimated $414K.
  • MRA Advisory Group first reported a position in CVS Health in Q1 2021 and held it in 11 quarters.
  • MRA Advisory Group's CVS Health position peaked at $705K in Q4 2021.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on MRA Advisory Group's 13F filing for Q4 2023, filed 12 Feb 2024.